Looking ahead to the digital age

Article

While nothing can replace the feel of a new hardbound book, I have submitted to the electronic reader.

The latest digital event to invade the eye-care world was the first Vision Expo Online, held Nov. 10. Optometrists, opticians, and office personnel packed real-time continuing education (CE) classes. Approximately 150 unique users purchased more than 900 hours of CE courses. The virtual exhibit hall was also crowded; several exhibitors were on hand to answer questions.

In closing, I look forward to seeing all of you at the real-life International Vision Expo East in New York City, March 17-20.

Author InfoKirk L. Smick, OD, FAAO, is chief of optometry services at Clayton Eye Center, Morrow, GA, and an owner of the facility. Dr. Smick also serves as a technical advisor to many companies in the ophthalmic industry and has helped pioneer several visual advances, including bifocal contact lenses.

Recent Videos
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.